validation-protocol

A GxP validation protocol verifies that clinical Electronic Data Capture (EDC) systems meet regulatory requirements like FDA 21 CFR Part 11 and GAMP 5. It documents Installation, Operational, and Performance Qualification (IQ/OQ/PQ) test scripts and traceability matrices to ensure system compliance before deployment.

You can generate IQ, OQ, and PQ test scripts for an Electronic Data Capture (EDC) system by using automated validation protocol generation. This process creates detailed test scripts and traceability matrices aligned with GAMP 5 risk-based methodology and 21 CFR Part 11 requirements.

Yes, 21 CFR Part 11 compliance requires a traceability matrix in validation protocols to link test cases directly to system requirements. This ensures that all regulatory and functional specifications for clinical trial software are verified during the IQ, OQ, and PQ phases.

Yes, you can use a GAMP 5 risk-based approach for clinical software validation. This methodology integrates with FDA 21 CFR Part 11 and EU Annex 11 requirements to generate validation protocols that focus testing efforts on critical system functions and patient safety risks.

The best way to document EU Annex 11 compliance for clinical trials is to generate comprehensive validation protocols. These protocols cover Installation, Operational, and Performance Qualification (IQ/OQ/PQ) phases with detailed test scripts and traceability matrices aligned with GAMP 5 standards.

You need a validation protocol for clinical Electronic Data Capture (EDC) systems before they go live in a clinical trial. This protocol ensures the software meets FDA 21 CFR Part 11, EU Annex 11, and GAMP 5 regulatory requirements through documented IQ, OQ, and PQ testing.